Navigation Links
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Date:9/3/2013

ALISO VIEJO, Calif., Sept. 3, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application (ANDA) seeking approval to market generic versions of Avanir's NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) capsules.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO )

The settlement agreement grants Actavis the right to begin selling a generic version of NUEDEXTA on July 30, 2026, or earlier under certain circumstances. The parties have also agreed to file a stipulation and order of dismissal with the United States District Court for the District of Delaware which will conclude this litigation with respect to Actavis. The settlement does not end Avanir's ongoing litigation against the other three ANDA filers.

In compliance with U.S. law, the settlement agreement will be submitted to the U.S. Federal Trade Commission and the Department of Justice where it is subject to review.

About NUEDEXTA
NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide, the ingredient active in the central nervous system, and quinidine sulfate, a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA Important Safety Information
NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrel
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
2. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
3. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
4. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
5. Avanir Pharmaceuticals to Participate in Two Conferences in August
6. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
8. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
9. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
10. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
11. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) has ... - Growth, Trends And Forecasts (2014 - 2019)" ... for Fluoroscopy is expected to grow at a healthy ... used to view the gastrointestinal tract, to direct the ... or the urinary system, to open narrowed or blocked ...
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ( ... "Specialty Enzymes - Global Strategic Business Report" report ... analyzed by the following End-Use Applications: Pharmaceutical & Diagnostics, ... analytics for the US, Canada , ... , Asia-Pacific , Latin ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2
... 14, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. ... Inc.) ("China Botanic" or the "Company"), a developer, ... traditional Chinese medicines ("TCM") in China, today announced ... Enterprise assessment, and that as a result, China ...
... 14, 2011 Reportlinker.com announces that a new ... Global Cardiac Monitoring Systems Market ... With advancements in technology, innovative product offerings ... introduced in the Cardiac Monitoring Systems market. Further, ...
Cached Medicine Technology:China Botanic Pharmaceutical Receives a Tax Exemption in 2011 2China Botanic Pharmaceutical Receives a Tax Exemption in 2011 3Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 2Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 3
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
(Date:6/2/2015)... California (PRWEB) June 02, 2015 ... and sorbent systems, has announced the availability of ... ingestion of poisons by children, especially curious toddlers. ... D3475 standards and tested to CFR 1700.20 protocols. ... Kevin Cullen. , Looks Like Candy, “With the ...
(Date:6/2/2015)... 02, 2015 Acara Partners has seen a ... responsive to mobile devices, as is now required by recent ... clients, as well as several new clients in the medical ... website for them to meet Google’s new requirements,” commented Fran ... with our clients in education, non-profits, and the business world.” ...
(Date:6/2/2015)... Nashville, Tennessee (PRWEB) June 02, 2015 ... leading functional drug response profiling test to help ... from the College of American Pathologists (CAP) for ... “Receiving the CAP certification is equivalent to the ... Henry, president and chief executive officer for DiaTech. ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... Researchers at the University of Pennsylvania School of Medicine ... cells from metastasizing from a primary tumor to other ... the "on" position, maintains the normal character of cells ... These epithelial cells are the type of cell from ...
... The following is being released by We Work ... Health of Maryland is a coalition of leaders in ... that will discuss the impact of the bioscience community ... and growth of medical innovation in Maryland.President Obama has ...
... March 16 PoggiCo Development is pleased to announce ... use in purchasing new medical office condominiums in Macomb ... is to assist small businesses in acquiring new buildings ... buying commercial real estate. Through the availability of ...
... Online Programs Will Deliver Educational Training and ... March 16 PulseLearning, a leading Ireland-based ... an agreement to develop customized eLearning and ... Chartered Property Casualty Underwriters and the Insurance ...
... (NYSE: MHS ) Chairman and CEO David ... Luncheon Address to the American Enterprise Institute,s health care ... March 18, 2009, at 12:30 p.m. Through the ... be directed at expanding the use of health information ...
... updates to the NCCN Clinical Practice Guidelines in Oncology(TM) ... on March 14. Notable updates include a new page ... of small molecule kinase inhibitors, and revised procedures for ... University of Texas M.D. Anderson Cancer Center ...
Cached Medicine News:Health News:Master molecular switch may prevent the spread of cancer cells to distant sites in the body 2Health News:Master molecular switch may prevent the spread of cancer cells to distant sites in the body 3Health News:Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures for Cancer and Other Diseases and Supporting the Economy 2Health News:Ireland's PulseLearning Inks Agreement With Leading U.S. Insurance Industry Association 2Health News:Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: 'Health IT: Empowering Precision Medicine' 2Health News:NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma 2Health News:NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma 3Health News:NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: